Thank you to our volunteers who continue to make a huge contribution to medicine

Volunteers who took part in a study back in 2011 that investigated a treatment for acute skin infections have contributed to a new medication called Baxdela making it to the US market.

Baxdela offers a new option for the treatment of adult patients with severe bacterial skin and skin structure infections.

Yet again, thank you to our volunteers who continue to make a huge contribution to medicine by taking part in clinical trials with us.